Feb 26, 2026 07:00AM
Jan 6, 2026 07:30AM
Nov 6, 2025 07:00AM
Oct 24, 2025 09:00AM
Oct 24, 2025 09:00AM
Oct 13, 2025 12:02PM
Oct 13, 2025 12:02PM Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
Sep 1, 2025 08:00PM
Aug 7, 2025 06:00AM
Jun 2, 2025 07:00AM
May 31, 2025 03:08PM
May 19, 2025 07:02AM
May 19, 2025 07:00AM
May 8, 2025 06:00AM Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates
Apr 23, 2025 10:56AM
Apr 21, 2025 07:30AM
Mar 12, 2025 07:30PM
Feb 27, 2025 06:00AM
Jan 22, 2025 11:16PM
Jan 22, 2025 11:15PM
Jan 17, 2025 07:30AM Zai Lab (ZLAB) Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia
Jan 17, 2025 07:30AM
Jan 15, 2025 07:30AM
Nov 27, 2024 11:05PM
Nov 21, 2024 04:00AM
Nov 12, 2024 06:30AM
Aug 6, 2024 04:05PM
Jul 16, 2024 12:15AM Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China
May 20, 2024 12:21AM
May 12, 2024 08:20PM
May 8, 2024 04:05PM
Apr 1, 2024 07:30AM
Feb 27, 2024 04:05PM
Jan 10, 2024 05:12PM
Dec 13, 2023 08:53AM Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug List
Nov 7, 2023 04:05PM
Jun 6, 2023 08:05AM
Apr 27, 2023 07:30AM
Mar 20, 2023 06:35AM
Mar 1, 2023 04:01PM
Feb 22, 2023 07:30AM
Jan 30, 2023 07:30AM Zai Lab Announces NDA for Sulbactam-Durlobactam (SUL-DUR) Granted Priority Review by China’s NMPA
Jan 5, 2023 07:34AM
Nov 9, 2022 04:01PM
Nov 8, 2022 07:30AM
Sep 27, 2022 08:00AM
Sep 27, 2022 08:00AM
Aug 9, 2022 04:05PM
Aug 8, 2022 07:12AM Zai Lab Limited (ZLAB) Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia
Aug 8, 2022 07:02AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All